Literature DB >> 2316213

Investigation of Lewis phenotypes in Polynesians: evidence of a weak secretor phenotype.

S M Henry1, A G Benny, D G Woodfield.   

Abstract

The salivary ABH and Lewis antigens of Polynesians were measured using a standardised red cell agglutination microplate assay and compared with the red cell defined Lewis phenotypes. Salivary ABH substances were detected in almost all saliva samples tested, with low levels (partial secretion) of ABH substances in the saliva from Le(a+b-) and Le(a+b+) individuals. Salivary Leb substance was detected in all Le(a-b+) and Le(a+b+) samples and in almost all Le(a+b-) samples. It is evident from the results obtained that Polynesian red cell phenotypes cannot be used to predict the presence or absence of salivary substances. If the presence of a coding secretor gene is presumed responsible for salivary ABH antigens and salivary Leb antigen expression, then the incidence of a coding secretor gene in Polynesians is 98%. These results indicate that the recessive non-secretor gene is absent or rare in a Polynesian derived gene pool. Two variants of secretor individuals are found among Polynesians, secretors with expression of normal amounts of the product of the secretor gene, similar to Caucasians, and partial secretors with weak expression of the secretor gene products.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2316213     DOI: 10.1111/j.1423-0410.1990.tb02057.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  9 in total

1.  Immunochemical and immunohistological expression of Lewis histo-blood group antigens in small intestine including individuals of the Le(a+b+) and Le(a-b-) nonsecretor phenotypes.

Authors:  S M Henry; B E Samuelsson; R Oriol
Journal:  Glycoconj J       Date:  1994-12       Impact factor: 2.916

2.  Ethnic differences in the expression of blood group antigens in the salivary gland secretory cells from German and Japanese non-secretor individuals.

Authors:  A Tanegashima; K Nishi; T Fukunaga; S Rand; B Brinkmann
Journal:  Glycoconj J       Date:  1996-08       Impact factor: 2.916

3.  Molecular basis for erythrocyte Le(a+ b+) and salivary ABH partial-secretor phenotypes: expression of a FUT2 secretor allele with an A-->T mutation at nucleotide 385 correlates with reduced alpha(1,2) fucosyltransferase activity.

Authors:  S Henry; R Mollicone; P Fernandez; B Samuelsson; R Oriol; G Larson
Journal:  Glycoconj J       Date:  1996-12       Impact factor: 2.916

4.  Correlation of a missense mutation in the human Secretor alpha 1,2-fucosyltransferase gene with the Lewis(a+b+) phenotype: a potential molecular basis for the weak Secretor allele (Sew).

Authors:  L C Yu; Y H Yang; R E Broadberry; Y H Chen; Y S Chan; M Lin
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

5.  Conserved residues Arg188 and Asp302 are critical for active site organization and catalysis in human ABO(H) blood group A and B glycosyltransferases.

Authors:  Susannah M L Gagnon; Max S G Legg; Robert Polakowski; James A Letts; Mattias Persson; Shuangjun Lin; Ruixiang Blake Zheng; Brian Rempel; Brock Schuman; Omid Haji-Ghassemi; Svetlana N Borisova; Monica M Palcic; Stephen V Evans
Journal:  Glycobiology       Date:  2018-08-01       Impact factor: 4.313

6.  Evidence for ethnic tropism of Helicobacter pylori.

Authors:  S Campbell; A Fraser; B Holliss; J Schmid; P W O'Toole
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

7.  Expression of Lewis histo-blood group glycolipids in the plasma of individuals of Le(a+b+) and partial secretor phenotypes.

Authors:  S M Henry; R Oriol; B E Samuelsson
Journal:  Glycoconj J       Date:  1994-12       Impact factor: 2.916

8.  Rhesus monkey gastric mucins: oligomeric structure, glycoforms and Helicobacter pylori binding.

Authors:  Sara Lindén; Thomas Borén; André Dubois; Ingemar Carlstedt
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

9.  Higher frequency of secretor phenotype in O blood group - its benefits in prevention and/or treatment of some diseases.

Authors:  Mohamad Salih Jaff
Journal:  Int J Nanomedicine       Date:  2010-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.